September 2016
Volume 57, Issue 12
Open Access
ARVO Annual Meeting Abstract  |   September 2016
Pharmacologic Inhibition of Intermediate Filament Accumulation in Astrocytes and Müller Glia Mediates Retinal Neuroprotection
Author Affiliations & Notes
  • Jeremy M Sivak
    Vision Sciences, Krembil Research Institute, University Health Network, Toronto, Ontario, Canada
    Vision Sciences and Ophthalmology, University of Toronto, Toronto, Ontario, Canada
  • Darren Chan
    Vision Sciences, Krembil Research Institute, University Health Network, Toronto, Ontario, Canada
    Vision Sciences and Ophthalmology, University of Toronto, Toronto, Ontario, Canada
  • Xiaoxin Guo
    Vision Sciences, Krembil Research Institute, University Health Network, Toronto, Ontario, Canada
  • Izzy Livne-Bar
    School of Optometry, University of California at Berkeley, Berkeley, California, United States
  • Footnotes
    Commercial Relationships   Jeremy Sivak, Genentech (F); Darren Chan, None; Xiaoxin Guo, None; Izzy Livne-Bar, None
  • Footnotes
    Support  CIHR (MOP123448), NSERC (RGPIN-2015-06561), GRSC
Investigative Ophthalmology & Visual Science September 2016, Vol.57, 4187. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Jeremy M Sivak, Darren Chan, Xiaoxin Guo, Izzy Livne-Bar; Pharmacologic Inhibition of Intermediate Filament Accumulation in Astrocytes and Müller Glia Mediates Retinal Neuroprotection. Invest. Ophthalmol. Vis. Sci. 2016;57(12):4187.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Astrocyte reactivity in the retina is primarily characterized by accumulations of the type III intermediate filaments (IFs) vimentin and glial fibrillary acidic protein (GFAP). However it has proven challenging to modulate this accumulation under pathological conditions to explore the roles of this process experimentally. We conducted experiments with the small molecule antagonist, withaferin A (WFA), to block type III IF dynamics in vivo in conjunction with metabolic retinal injury, and in combination with a model of induced astrocyte reactivity.

Methods : Apoptosis of inner retinal neurons was induced in C57bl/6 mice by excitotoxic injury in combination with vehicle or WFA treatment. This injury model has been established to be dependent on astrocyte and müller glial derived secretion of TNF-α. In addition, this model was combined with induced retinal glial reactivity through transient corneal injury. Glial reactivity and retinal ganglion cell (RGC) apoptosis were imaged and quantified through immunofluorescence microscopy. TNF-α levels were also measured by immunofluorescent and ELISA based methods.

Results : WFA treatment significantly blocked glial reactivity and RGC apoptosis by 80% and 60%, respectively. Induced glial reactivity exacerbated the gliosis by 16 fold, and RGC damage by 7 fold. This increased vulnerability in both parameters was completely rescued by WFA treatment. WFA inhibited p38 mediated TNF-α secretion in cultured retinal astrocytes, and significantly reduced injury induced TNF-α immunoreactivity in the inner retina in vivo.

Conclusions : Inhibition of IF dynamics effectively protected the inner retina from excitoxic damage. Our results suggest this mechanism is regulated through release of TNF-α by retinal astrocytes and müller glia.

This is an abstract that was submitted for the 2016 ARVO Annual Meeting, held in Seattle, Wash., May 1-5, 2016.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×